Primary Urethral Carcinoma in Females: an Epidemiologic Study on Demographical Factors, Histological Types, Tumour Stage and Survival

Overview

Journal World J Urol

Specialty Urology

Date 2012 May 23

PMID 22614443

Citations 28

Authors

Joris W Derksen

Otto Visser

Guy Brutel de la Riviere

Eric J Meuleman

Eddi A Heldeweg

Brunolf W Lagerveld

Affiliations

Soon will be listed here.

Abstract

Purpose: To obtain insight into demographical factors, histology and survival rates of females diagnosed with primary urethral cancer and to determine favourable treatment.

Methods: Data from 91 females with primary urethral carcinoma, age varying from 15 to 85 years, registered between 1989 and 2008 at the National Cancer Registry of the Netherlands were used for this study. Demographical factors, incidence rate, morphology and tumour stage according to TNM classification were analysed. Kaplan-Meier survival curves were constructed and stratified by stage, histological type and treatment modality.

Results: The overall crude annual incidence was 0.7 per million women with a peak incidence in the age group of 80-84 years. Analysis of the morphology showed urothelial cell carcinoma (UCC) in 45 %, squamous cell carcinoma (SCC) in 19 %, adenocarcinoma (AC) in 29 %, and unknown or undifferentiated carcinoma accounted for 6 %. Almost half of patients (46 %) had advanced disease at time of diagnosis and was mainly treated with surgery and/or radiotherapy. The 5-year survival rates of stage 0-II, stage III and stage IV were 67, 53 and 17 %, respectively. The 5-year survival rates of SCC, UCC and AC were 64, 61 and 31 %, respectively.

Conclusions: Female primary urethral carcinoma is a rare condition, and the majority of patients were aged above 65 years. Almost half of patients have advanced disease upon diagnosis. TNM stage and histological type of disease are the most determining factors for survival. Extended surgery with or without radiotherapy seems to be the most favourable treatment. Awareness and early diagnosis are important to improve survival.

Citing Articles

CDX2- and PAX8-Expressing Subtypes in Female Urethral Adenocarcinoma: Pathogenesis Insights through Immunohistochemical and Morphological Analyses.

Sugawara E, Shigematsu Y, Amori G, Sugita K, Yonese J, Takeuchi K Diagnostics (Basel). 2023; 13(14).

PMID: 37510152 PMC: 10377779. DOI: 10.3390/diagnostics13142408.

Progress in the treatment of urethral adenocarcinoma.

Guo J, Liang X, Zheng Y, Ma J J Cancer Res Clin Oncol. 2022; 149(6):2693-2698.

PMID: 36414814 DOI: 10.1007/s00432-022-04481-5.

Primary Malignant Melanoma of the Genitourinary System: A Systemic Review and Report of Eight Cases.

Khayyat A, Esmaeil Pour M, Mousavi S, Khalili-Toosi A, Amin A Cureus. 2022; 14(10):e30444.

PMID: 36407184 PMC: 9671744. DOI: 10.7759/cureus.30444.

A brief review on the diagnostic and therapeutic principles of primary urethral cancer.

Su H, Zhu Y, Ye D Asian J Urol. 2022; 9(4):423-429.

PMID: 36381601 PMC: 9643286. DOI: 10.1016/j.ajur.2022.04.005.

Chemotherapy combined with immunotherapy in primary female urethral squamous cell carcinoma: a case report.

Bai H, Han H, Wang F, Shi H J Int Med Res. 2022; 50(10):3000605221132418.

PMID: 36281031 PMC: 9608069. DOI: 10.1177/03000605221132418.

References

Swartz M, Porter M, Lin D, Weiss N . Incidence of primary urethral carcinoma in the United States. Urology. 2006; 68(6):1164-8. DOI: 10.1016/j.urology.2006.08.1057. View

Gerrard Jr E, Lloyd L, Kubricht W, Kolettis P . Transvaginal ultrasound for the diagnosis of urethral diverticulum. J Urol. 2003; 169(4):1395-7. DOI: 10.1097/01.ju.0000056739.53193.6c. View

Meis J, Ayala A, Johnson D . Adenocarcinoma of the urethra in women. A clinicopathologic study. Cancer. 1987; 60(5):1038-52. DOI: 10.1002/1097-0142(19870901)60:5<1038::aid-cncr2820600519>3.0.co;2-#. View

Shigehara K, Sasagawa T, Kawaguchi S, Kobori Y, Nakashima T, Shimamura M . Prevalence of human papillomavirus infection in the urinary tract of men with urethritis. Int J Urol. 2010; 17(6):563-8. DOI: 10.1111/j.1442-2042.2010.02521.x. View

Foens C, Hussey D, Staples J, Doornbos J, Wen B, Vigliotti A . A comparison of the roles of surgery and radiation therapy in the management of carcinoma of the female urethra. Int J Radiat Oncol Biol Phys. 1991; 21(4):961-8. DOI: 10.1016/0360-3016(91)90736-n. View

van der Sanden G, Coebergh J, Schouten L, Visser O, van Leeuwen F . Cancer incidence in The Netherlands in 1989 and 1990: first results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries. Eur J Cancer. 1995; 31A(11):1822-9. DOI: 10.1016/0959-8049(95)00355-m. View

Nurenberg P, Zimmern P . Role of MR imaging with transrectal coil in the evaluation of complex urethral abnormalities. AJR Am J Roentgenol. 1997; 169(5):1335-8. DOI: 10.2214/ajr.169.5.9353453. View

Sailer S, Shipley W, Wang C . Carcinoma of the female urethra: a review of results with radiation therapy. J Urol. 1988; 140(1):1-5. DOI: 10.1016/s0022-5347(17)41469-8. View

Touijer A, Dalbagni G . Role of voided urine cytology in diagnosing primary urethral carcinoma. Urology. 2004; 63(1):33-5. DOI: 10.1016/j.urology.2003.08.007. View

10.

Dalbagni G, Zhang Z, Lacombe L, Herr H . Female urethral carcinoma: an analysis of treatment outcome and a plea for a standardized management strategy. Br J Urol. 1999; 82(6):835-41. DOI: 10.1046/j.1464-410x.1998.00878.x. View

11.

Drew P, MURPHY W, Civantos F, Speights V . The histogenesis of clear cell adenocarcinoma of the lower urinary tract. Case series and review of the literature. Hum Pathol. 1996; 27(3):248-52. DOI: 10.1016/s0046-8177(96)90064-7. View

12.

Sun K, Huan Y, Unger P . Clear cell adenocarcinoma of urinary bladder and urethra: another urinary tract lesion immunoreactive for P504S. Arch Pathol Lab Med. 2008; 132(9):1417-22. DOI: 10.5858/2008-132-1417-CCAOUB. View

13.

Hahn P, Krepart G, Malaker K . Carcinoma of female urethra. Manitoba experience: 1958-1987. Urology. 1991; 37(2):106-9. DOI: 10.1016/0090-4295(91)80202-i. View

14.

Hampl M, Deckers-Figiel S, Hampl J, Rein D, Bender H . New aspects of vulvar cancer: changes in localization and age of onset. Gynecol Oncol. 2008; 109(3):340-5. DOI: 10.1016/j.ygyno.2008.01.041. View

15.

Hosseinzadeh K, Furlan A, Torabi M . Pre- and postoperative evaluation of urethral diverticulum. AJR Am J Roentgenol. 2007; 190(1):165-72. DOI: 10.2214/AJR.07.2094. View

16.

Maier U, Dorfinger K, Susani M . Clear cell adenocarcinoma of the female urethra. J Urol. 1998; 160(2):492-3. View

17.

Narayan P, Konety B . Surgical treatment of female urethral carcinoma. Urol Clin North Am. 1992; 19(2):373-82. View

18.

GRABSTALD H, Hilaris B, HENSCHKE U, WHITMORE Jr W . Cancer of the female urethra. JAMA. 1966; 197(11):835-42. View

19.

Wiener J, Walther P . A high association of oncogenic human papillomaviruses with carcinomas of the female urethra: polymerase chain reaction-based analysis of multiple histological types. J Urol. 1994; 151(1):49-53. DOI: 10.1016/s0022-5347(17)34870-x. View

20.

DiMarco D, DiMarco C, Zincke H, Webb M, Bass S, Slezak J . Surgical treatment for local control of female urethral carcinoma. Urol Oncol. 2004; 22(5):404-9. DOI: 10.1016/S1078-1439(03)00174-1. View